July 17, 2023: The Cooper Davis Act heads out of committee

Legislation moves forward in the Senate for social media platforms to report dealers to the DEA. A Shanghai resident sentenced for selling counterfeit cat medicine. Missouri resident sentenced for injecting clients with non-FDA-approved Botox and fillers, hurting multiple people. Stories of counterfeit pills in 17 states.

[...]

July 5, 2023: Federal authorities move on black market HIV drug sales

The FDA warned Safe Chain Solutions for trading with unlicensed sellers. Other black market HIV drug cases are moving forward. The CDC reported a spike in fentanyl/xylazine deaths. Authorities seized a pill press, smuggled codeine and millions of counterfeit pills made of fentanyl. Prosecutions involved the trafficking of and deaths related to fentanyl pills in 10 states.

[...]

FDA Alert: Suprimo Imports Warned by FDA After Reports of Illness and Death Due to Prescription Drug Ingredients in Their Dietary Supplements.

“On April 20, 2022, FDA warned consumers not to purchase or use “Artri Ajo King” as FDA has received adverse event reports, including of liver toxicity and death, associated with the use of “Artri Ajo King” and similarly named products. While the Agency has not sampled and tested this product from your inventory to date, be advised of our serious concern about the safety of these products and that it is your legal responsibility under federal law to ensure this product does not contain any undeclared and potentially harmful ingredients.”

[...]